Protea F.-Sec.Healthcare Opp.Fd.PH H
LU1849505026
Protea F.-Sec.Healthcare Opp.Fd.PH H/ LU1849505026 /
NAV22/08/2024 |
Var.-0.0300 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
270.5700EUR |
-0.01% |
reinvestment |
Equity
Worldwide
|
FundPartner Sol.(EU) ▶ |
Investment strategy
The Sub-Fund invests primarily in innovative healthcare companies developing differentiated drugs, services, life science tools and devices in therapeutic areas with large unmet medical needs. Investments are made across all market caps and geographies, including the emerging markets, with significant exposure to mid- and small-cap companies, due to their high degree of innovation. Novel and differentiated treatments, devices, and services benefit from a favorable regulatory and commercial environment, with the potential for shortened development timelines, rapid market adoption as well as strong pricing and operating margins. Innovation in healthcare delivery and novel therapeutic modalities has created new business models and markets with tremendous commercial potential.
In order to achieve this objective, the Sub-Fund invests, while respecting the principle of risk diversification, primarily in equities (including, but not limited to, common stocks, preferred stocks, or other securities convertible into common stock) and equity related securities (such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs), European Depositary Receipts (EDRs)) issued by mid and large cap issuers which are located worldwide (with a maximum exposure of 33% to emerging markets) and which are active in the following healthcare sectors: healthcare equipment and services, pharmaceuticals, biotechnology and life sciences. The Sub-Fund may, invest in transferable securities and money market instruments from new issues to benefit from particularly innovative projects in the healthcare sector. The Sub-Fund may invest up to 33% of its net assets via Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect in China A-Shares. Up to 10% of the Sub-Fund's net assets may be invested in Special Purpose Acquisition Companies. Up to 33% of the Sub-Fund's net assets may be invested outside the aforementioned investment universe including but not limited to equities of issuers of other business segments than healthcare, in fixed and variable interest securities. The Sub-Fund may not invest more than 10% of its net assets in other UCIs or UCITS.
Investment goal
The Sub-Fund invests primarily in innovative healthcare companies developing differentiated drugs, services, life science tools and devices in therapeutic areas with large unmet medical needs. Investments are made across all market caps and geographies, including the emerging markets, with significant exposure to mid- and small-cap companies, due to their high degree of innovation. Novel and differentiated treatments, devices, and services benefit from a favorable regulatory and commercial environment, with the potential for shortened development timelines, rapid market adoption as well as strong pricing and operating margins. Innovation in healthcare delivery and novel therapeutic modalities has created new business models and markets with tremendous commercial potential.
Dati master
Type of yield: |
reinvestment |
Fondi Categoria: |
Equity |
Region: |
Worldwide |
Settore: |
Sector Health / Pharma |
Benchmark: |
MSCI TR World Net Health Care USD Index |
Business year start: |
01/07 |
Ultima distribuzione: |
- |
Banca depositaria: |
Bank Pictet & Cie (Europe) AG |
Domicilio del fondo: |
Luxembourg |
Permesso di distribuzione: |
Austria, Germany, Switzerland |
Gestore del fondo: |
- |
Volume del fondo: |
112.43 mill.
USD
|
Data di lancio: |
30/04/2007 |
Investment focus: |
- |
Condizioni
Sovrapprezzo emissione: |
2.00% |
Tassa amministrativa massima: |
1.19% |
Investimento minimo: |
0.00 EUR |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Prospetto semplificato: |
Download (Print version) |
Società d'investimento
Funds company: |
FundPartner Sol.(EU) |
Indirizzo: |
15A, avenue J. F. Kennedy, 1855, Luxemburg |
Paese: |
Luxembourg |
Internet: |
www.group.pictet/de
|
Attività
Stocks |
|
99.95% |
Altri |
|
0.05% |
Paesi
Korea, Republic Of |
|
91.48% |
United States of America |
|
3.79% |
Denmark |
|
2.79% |
China |
|
0.39% |
Brazil |
|
0.35% |
United Kingdom |
|
0.26% |
Malaysia |
|
0.26% |
Switzerland |
|
0.18% |
Ireland |
|
0.17% |
Altri |
|
0.33% |
Filiali
Healthcare services |
|
93.11% |
Pharma/Biotechnology |
|
5.43% |
Healthcare appliances |
|
1.32% |
Gesundheitswesen/ Informationstechnologie |
|
0.10% |
Altri |
|
0.04% |